Bahl & Gaynor Inc Celgene Corp. Transaction History

Bahl & Gaynor Inc

  • $19.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 11, 2018
SELL
N/A
-2,360 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
N/A
-515 Reduced 17.91%
2,360 $344,000
Q2 2017

Aug 11, 2017
BUY
N/A
2,875
2,875 $373,000
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email